This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Kiran N Mahajan: Innovator in Cancer Therapy
Introduction
Kiran N Mahajan is a prominent inventor based in Tampa, Florida, known for his significant contributions to cancer therapies. With a total of five patents to his name, he has made strides in the field of oncology through innovative research and development.
Latest Patents
Among his latest patents are the inhibitors of ACK1/TNK2 tyrosine kinase. These patents describe novel cancer therapies and anti-cancer compounds. Specifically, they disclose inhibitors of ACK1 tyrosine kinase and their application in treating cancer. Additionally, methods for screening new ACK1 tyrosine kinase inhibitors are outlined, with specific examples of compounds having Formula I through IV being disclosed.
Career Highlights
Kiran N Mahajan is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he conducts his research. His work focuses on developing effective treatments for cancer, contributing to the advancement of medical science.
Collaborations
Some of his notable coworkers include Nupam Mahajan and Nicholas James Lawrence, who collaborate with him in his research endeavors.
Conclusion
Kiran N Mahajan's innovative work in cancer therapies showcases his dedication to improving treatment options for patients. His patents reflect a commitment to advancing medical research and finding solutions to complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile